Common use of Development Milestone Payments Clause in Contracts

Development Milestone Payments. In the event that the Company, Sublicensees, or their Affiliates (collectively “Developer”) develops a Product for commercial sale in the Territory, the following nonrefundable, non-recoverable and non-creditable milestone payments shall be made by Company to Columbia with respect to the first Product as follows: [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] The above milestone payment shall be paid on the first Product and first indication only.

Appears in 2 contracts

Sources: Exclusive License Agreement (Belite Bio, Inc), Exclusive License Agreement (Belite Bio, Inc)

Development Milestone Payments. In the event that the Company, Sublicensees, or their Affiliates (collectively “Developer”) develops a Product for potential commercial sale in the Territory, the following nonrefundable, non-recoverable and non-non- creditable milestone payments shall be made by Company to Columbia with respect to the first each and every such Product as follows: [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] The above milestone payment shall be paid on the first Product and first indication only.:

Appears in 1 contract

Sources: Exclusive License Agreement

Development Milestone Payments. In the event that the Company, Sublicensees, or their Affiliates (collectively “Developer”) develops a Product for potential commercial sale in the Territory, the following nonrefundable, non-recoverable and non-creditable milestone payments shall be made by Company to Columbia with respect to the first Product to reach each milestone or when specific milestones are first achieved, as follows: applicable (collectively, the “Developer Milestone Payments”): i. [***] ]; ii. [***] ]; iii. [***] ]; iv. [***] ]; v. [***] ]; and vi. [***] [***] [***] [***] [***] The above milestone payment shall be paid on the first Product and first indication only].

Appears in 1 contract

Sources: Exclusive License Agreement (Vor Biopharma Inc.)

Development Milestone Payments. In the event that the Company, Sublicensees, or their Affiliates (collectively “Developer”) develops a Product for potential commercial sale in the Territory, the following nonrefundable, non-recoverable and non-creditable milestone payments shall be made by Company to Columbia with respect to the first Product to reach each milestone or when the milestone is first achieved, as follows: applicable (collectively, the “Developer Milestone Payments”): (i) [***] ]; (ii) [***] ]; (iii) [***] ] (iv) [***] ] (v) [***] ]; and (vi) [***] [***] [***] [***] [***] The above milestone payment shall be paid on the first Product and first indication only].

Appears in 1 contract

Sources: Exclusive License Agreement (Vor Biopharma Inc.)